Helixmith Announces Topline Results from Double-Blind Placebo Controlled Multicenter Study for TADIOS Involving 100 Subjects Infected with COVID-19
KEY POINTSTADIOS was determined to be safe and well toleratedSerum levels of IL-1RA changed significantly, a biomarker that has a...
